TY - JOUR
T1 - Interleukin-10 deficiency aggravates traumatic brain injury in male but not female mice
AU - Gu, Yanting
AU - Dong, Yinfeng
AU - Wan, Jieru
AU - Ren, Honglei
AU - Koehler, Raymond C.
AU - Wang, Jian
N1 - Funding Information:
This work was supported by a Stimulating and Advancing ACCM Research grant from the Department of Anesthesiology and Critical Medicine at Johns Hopkins University.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/9
Y1 - 2022/9
N2 - The goal of this study was to determine whether deficiency of anti-inflammatory cytokine interleukin-10 (IL-10) affects traumatic brain injury (TBI) outcomes in a sex-dependent manner. Moderate TBI was induced by controlled cortical impact in 8-10 week-old wild-type and IL-10–deficient mice. In wild-type mice, serum IL-10 was significantly increased after TBI in males but not in females. At 4–5 weeks after TBI, sensorimotor function, cognitive function (Y-maze and novel object recognition tests), anxiety-related behavior (light-dark box and open field test), and depression-like behavior (forced swim test) were assessed. IL-10–deficient male mice had larger lesion volumes than did wild-type mice in the early recovery phase and worse performance on sensorimotor tasks, cognitive tests, and anxiety- and depression-related tests in the late recovery phase, whereas female IL-10–deficient mice had lesion volume equivalent to that of wild-type females and worse performance only on sensorimotor tasks. At 3 days after TBI, the number of GFAP- and Iba1-positive cells were augmented in areas in proximity to the injury (cerebral cortex and hippocampus) and in remote functional regions (striatum and amygdala) of IL-10–deficient male, but not female, mice. Moreover, on day 35, significantly fewer NeuN-positive cells were present in cortex, striatum, and amygdala of IL-10–deficient male mice than in wild-type males. This difference was not evident in females. We conclude that IL-10 deficiency aggravates cognitive and emotional recovery from TBI in association with enhanced gliosis and neuronal loss selectively in males, suggesting that recruitment of this cytokine limits damage in a sex-dependent manner.
AB - The goal of this study was to determine whether deficiency of anti-inflammatory cytokine interleukin-10 (IL-10) affects traumatic brain injury (TBI) outcomes in a sex-dependent manner. Moderate TBI was induced by controlled cortical impact in 8-10 week-old wild-type and IL-10–deficient mice. In wild-type mice, serum IL-10 was significantly increased after TBI in males but not in females. At 4–5 weeks after TBI, sensorimotor function, cognitive function (Y-maze and novel object recognition tests), anxiety-related behavior (light-dark box and open field test), and depression-like behavior (forced swim test) were assessed. IL-10–deficient male mice had larger lesion volumes than did wild-type mice in the early recovery phase and worse performance on sensorimotor tasks, cognitive tests, and anxiety- and depression-related tests in the late recovery phase, whereas female IL-10–deficient mice had lesion volume equivalent to that of wild-type females and worse performance only on sensorimotor tasks. At 3 days after TBI, the number of GFAP- and Iba1-positive cells were augmented in areas in proximity to the injury (cerebral cortex and hippocampus) and in remote functional regions (striatum and amygdala) of IL-10–deficient male, but not female, mice. Moreover, on day 35, significantly fewer NeuN-positive cells were present in cortex, striatum, and amygdala of IL-10–deficient male mice than in wild-type males. This difference was not evident in females. We conclude that IL-10 deficiency aggravates cognitive and emotional recovery from TBI in association with enhanced gliosis and neuronal loss selectively in males, suggesting that recruitment of this cytokine limits damage in a sex-dependent manner.
KW - Controlled cortical impact
KW - interleukin-10
KW - neurobehavior
KW - neuroinflammation
KW - traumatic brain injury
UR - http://www.scopus.com/inward/record.url?scp=85131122228&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131122228&partnerID=8YFLogxK
U2 - 10.1016/j.expneurol.2022.114125
DO - 10.1016/j.expneurol.2022.114125
M3 - Article
C2 - 35644427
AN - SCOPUS:85131122228
SN - 0014-4886
VL - 355
JO - Neurodegeneration
JF - Neurodegeneration
M1 - 114125
ER -